The North America tissue processing systems market is expected to reach US$ 252.56 million by 2027 from US$ 167.72 million in 2019; it is estimated to grow at a CAGR of 5.4% from 2020 to 2027.
The market growth is mainly attributed to the rising prevalence of cancer and increasing number of diagnostic laboratories in North America. However, the high cost of cancer diagnostics restricts the market growth.
Tissue processing involves preparing tissues for microscopic analysis by putting them in a tangible medium. It helps provide skinny and high-quality slices that can be mounted on the glass slides and properly stained to indicate normal and abnormal structures. Tissue processing systems are widely used in cancer diagnostic laboratories, where biopsy samples are processed for cancer diagnosis. The growing aging population, prone to chronic diseases such as cancer, drives the demand for regular diagnostic tests. As per estimates revealed by the National Cancer Institute, in the US, the rate of new cancer cases was 442.4 per 100,000 men and women per year, and the cancer death rate was 158.3 per 100,000 men and women per year during 2013–2017. Thus, the growing prevalence of cancer is likely to boost the demand for tissue processing products in cancer diagnosis. Also, the growing network of diagnostic laboratories in North America is favoring the growth of the tissue processing system market in this region.
The impact of COVID-19 pandemic on the tissue processing systems market in North America has been minor in the last year. Restrictions on cross-border trade in several countries worldwide were the key factors that disrupted the supply and demand of tissue processing products. However, in the long run, the market is expected to grow at a steady rate, owing to the precautions taken during the tissue processing system in North America.
North America Tissue processing systemsMarketRevenue and Forecast to 2027 (US$ Mn)

- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
North America Tissue processing systems MarketSegmentation
By Product
By Volume
- Small volume processors
- Medium volume processors
- Large volume processors
By End User
- Hospitals
- Pharmaceutical companies
- Research laboratories
- Others
By Country
- US
- Canada
- Mexico
Company Profiles
- Miltenyi Biotec
- BioGenex
- Leica Biosystems Nussloch GmbH (Danaher)
- Avantor, Inc.
- THERMO FISHER SCIENTIFIC INC.
- Siemens AG
- F. HOFFMANN-LA ROCHE LTD
- Agilent Technologies, Inc
- Milestone Medical
- Sakura Finetek USA, Inc.
North America Tissue Processing Systems Report Scope
Report Attribute | Details |
---|---|
Market size in 2019 | US$ 167.72 Million |
Market Size by 2027 | US$ 252.56 Million |
Global CAGR (2020 - 2027) | 5.4% |
Historical Data | 2017-2018 |
Forecast period | 2020-2027 |
Segments Covered |
By Product
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset



Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Product, Volume, End user, and Country

Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
US, Canada
Trends and growth analysis reports related to Life Sciences : READ MORE..
- Miltenyi Biotec
- BioGenex
- Leica Biosystems Nussloch GmbH (Danaher)
- Avantor, Inc.
- THERMO FISHER SCIENTIFIC INC.
- Siemens AG
- F. HOFFMANN-LA ROCHE LTD
- Agilent Technologies, Inc
- Milestone Medical
- Sakura Finetek USA, Inc.